Delivery Order SPE2DB24D9228-SPE2DB25FATHV
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,311.35 to DMS Pharmaceutical Group Inc. on September 3, 2025, for the supply of Xtandi 40 mg capsules (120-count units). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will fulfill this order for delivery to Park Ridge, IL. The contract utilizes a firm fixed-price structure with an ultimate completion date of September 4, 2025, and no set-aside designation...
- The Defense Logistics Agency awarded a delivery order valued at $4,311.35 to DMS Pharmaceutical Group Inc. for 120 capsules of Xtandi 40 mg on February 13, 2025, with an ultimate completion date of February 14, 2025. This firm fixed-price delivery order was issued without a set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected as the prime contractor. The company will perform the delivery from...
- The Defense Logistics Agency awarded a delivery order valued at $4,311.35 to DMS Pharmaceutical Group Inc. for the supply of Xtandi 40 mg capsules (120-unit quantity) on August 15, 2025. This firm fixed-price delivery order, which is set to be completed by August 18, 2025, represents a specific purchase order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park...
- The Defense Logistics Agency awarded a delivery order valued at $42,546.46 to DMS Pharmaceutical Group Inc. for the supply of Xtandi 40 mg capsules (120-count units) under a firm fixed-price contract type. This delivery order, issued on September 18, 2025, with an ultimate completion date of September 19, 2025, represents a time-sensitive pharmaceutical procurement with no set-aside designation applied. The products will be delivered to Park Ridge, Illinois, where DMS Pharmaceutical Group...
- The Defense Logistics Agency issued a firm fixed-price delivery order valued at $12,792.31 to DMS Pharmaceutical Group Inc. for the supply of Xtandi 40 mg capsules (120-count units). DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its Park Ridge location with completion expected by July 24, 2025. This delivery order was awarded without a set-aside designation, allowing the vendor to compete in the open...
- The Defense Logistics Agency awarded a delivery order valued at $16,961.90 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 120 capsules of Xtandi 40 mg. This firm fixed-price delivery order, issued on September 16, 2025, with an ultimate completion date of September 17, 2025, represents a specialized pharmaceutical supply requirement supporting Department of Defense healthcare operations. The award carries no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $4,311.35 to DMS Pharmaceutical Group Inc. for the supply of Xtandi 40 mg capsules (120-count units). This delivery order, issued on May 12, 2025, with an ultimate completion date of May 13, 2025, operates under a firm fixed-price arrangement with no set-aside designation. The order will be fulfilled from the vendor's location in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $12,934.05 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xtandi 40 mg capsules (quantity: 120). This firm fixed-price delivery order, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, represents a continuation of the ongoing pharmaceutical supply relationship between the agency and the vendor. The award carries no...
- The Defense Logistics Agency awarded a delivery order valued at $4,169.59 to DMS Pharmaceutical Group Inc. for the supply of Xtandi 80 mg tablets (60-count units). The contract, which became effective on July 23, 2025, with an ultimate completion date of July 24, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,311.35 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xtandi 40 mg capsules (120-count units). This firm fixed-price delivery order, awarded on September 3, 2025, with an ultimate completion date of September 4, 2025, was issued without a set-aside designation. The award represents a single delivery order issued under DMS...
- SPE2DB24D9228Indefinite Delivery Contract
- SPE2DB24D9228-SPE2DB25FATHVDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,311.35 to DMS Pharmaceutical Group Inc. for 120 capsules of Xtandi 40 mg on September 15, 2025, with completion targeted for September 16, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected under a firm fixed-price delivery order contract with no set-aside designation. The order will be fulfilled from the contractor's Park Ridge, Illinois location. This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the Defense Logistics Agency, valued at $499,999,999 and valid through November 2026. The IDC, which operates under the SPE2DB program, enables the agency to procure a comprehensive range of pharmaceutical products to support medical supply needs across Department of Defense healthcare facilities nationwide. Xtandi, an oncology treatment medication, represents one of many specialized pharmaceutical products within the contractor's extensive portfolio of branded and generic prescription drugs, biologics, and medical consumables delivered to military health facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 9/15/25 |